The findings presented in this manuscript are fundamental, as they uncover MYL3, a member of the myosin family, as a potential entry receptor and therapeutic target for a virus that poses a major ...

Tovar is one of nearly 200 young scientists across the nation whose research and job prospects have been jeopardized by the sudden termination of the NIH’s MOSAIC grant program, one of many ended by ...

Belgium is on the board! The Saskatchewan Roughriders added a 45 th country to their All-Time list of players’ birthplaces on Tuesday when Belgian-born defensive end Sylvain Yondjouen was selected in ...

Mosaic Artist Ed Chapman has successfully created biscuit versions of Judi Dench and David Bowie as part of his new work... He joins Seán to discuss.

At Martin Luther University Halle-Wittenberg in Germany, a team of researchers recently reported developing an RNA-based antiviral agent that confers strong protection against cucumber mosaic ...

Here, we show that forcing a metabolic change in embryonic stem cells (ESCs) promotes a developmental identity that better approximates the inner cell mass (ICM) of the early mammalian blastocyst in ...

Mosaic Therapeutics a UK-based oncology company has announced it has in-licensed two clinical-stage oncology programmes from Astex Pharmaceuticals. The agreement transforms Mosaic from a ...

Mosaic Therapeutics has secured the latest pieces in its combination medicine strategy by licensing two clinical stage tumor drugs from fellow British biotech Astex Pharmaceuticals. The small ...

Mosaic Therapeutics, Ltd ('Mosaic') a targeted oncology therapeutics company dedicated to resolving cancer's complexity with new combination therapies for patients, today announces the in ...

In-licensing these clinical-stage assets has significantly de-risked and accelerated Mosaic’s development path; the compounds will be developed as proprietary combination therapies Syncona Ltd, ...